Inhibition of inosine monophosphate dehydrogenase (IMPDH) by the antiviral compound, 2-vinylinosine monophosphate
Authors:
- 1 November 2002
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 10 (11) , 3615-3618
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Asp338 Controls Hydride Transfer in Escherichia coli IMP DehydrogenaseBiochemistry, 2000
- Kinetic Mechanism of Tritrichomonas foetus Inosine 5‘-Monophosphate DehydrogenaseBiochemistry, 1999
- Enzymatic Synthesis of Thymidine Using Bacterial Whole Cells and Isolated Purine Nucleoside PhosphorylaseBiocatalysis and Biotransformation, 1997
- Rationally Designed Inhibitors of Inosine Monophosphate DehydrogenaseJournal of Medicinal Chemistry, 1997
- Furanfurin and Thiophenfurin: Two Novel Tiazofurin Analogs. Synthesis, Structure, Antitumor Activity, and Interactions with Inosine Monophosphate DehydrogenaseJournal of Medicinal Chemistry, 1995
- Trends in the development of new antiviral agents for the chemotherapy of infections caused by herpesviruses and retrovirusesReviews in Medical Virology, 1995
- Probing the Active Site of Human IMP Dehydrogenase Using Halogenated Purine Riboside 5'-Monophosphates and Covalent Modification ReagentsBiochemistry, 1994
- New hypoxanthine nucleosides with RNA antiviral activityAntiviral Research, 1992
- New methodologies for the synthesis of C-2 functionalized hypoxanthine nucleosidesThe Journal of Organic Chemistry, 1988
- IMP dehydrogenase, an enzyme linked with proliferation and malignancyNature, 1975